Patient-specific targeted analysis of circulating tumour DNA in plasma is feasible and may be a potential biomarker in UTUC.

Ninni MuCecilia JylhäTomas AxelssonFilip SydénMarianne BrehmerEmma Tham

Published in: World journal of urology (2023)

Our early findings demonstrate that ctDNA in plasma can be detected by targeted analysis in patients with UTUC. However, further studies are needed to determine its role as a potential biomarker.

Keyphrases

circulating tumor
cancer therapy
single molecule
drug delivery
nucleic acid